OMER LongComplex pullback after a long upswing, couple of interesting candles showing price rejection in the lows, decent chance of a 2R trade
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.35 USD
−117.81 M USD
0.00 USD
55.36 M
About Omeros Corporation
Sector
CEO
Gregory A. Demopulos
Headquarters
Seattle
Website
Founded
1994
FIGI
BBG000JLP4B4
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
OMER Stock - Medical Breakthrough with Short SqueezeOn its current trajectory, Omeros Corporation (NASDAQ: OMER) might be heading into a short squeeze thanks to its high short data. With this in mind, a short squeeze requires a catalyst to help the stock run and OMER stock has no shortage of upcoming catalysts. As we are in the second half of 2023, O
omer daily accumulation buy/hold TP 400% gains🔸Hello traders, let's review the daily price chart for OMER today. We got strong ongoing
accumulation in range since april 2022. Trading in well defined range and chart looks good.
Range highs set near 5.8 usd and range lows set at 2.50 usd. Premium prices overhead at
7.50 usd and below at 1.80/2.00
OMER - High risk play. Short squeeze opportunityOpportunity for a massive short squeeze. Need volume to confirm a short squeeze is taking place. Stop below today's low.
Short float >20%.
You don't need to know what's going to happen next to make money ~Mark Douglas
Lose like a pro and keep trading, or lose like a novice and quit ~Mark Ritchie
OMER at 2013 level. Time to buy? In 2021 Omeros Corporation (OMER) delivered great results, net income was $194.2 million or $3.12 per share VS a net loss of $138.1 million or $2.41 net loss per share in 2020.
On 1/18/2022 Cantor Fitzgerald Lower Price Target for OMER from $34.00 to $20.00.
I think a reversal to the $8.50 resi
Short squeeze mini series 7.Since short squeezes are the fashion now, this is a mini series for them #7
BLA for Narsoplimab in HSCT-TMA Accepted for Priority Review Biologics License Application for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA
-- FDA sets PDUFA date of July 17, 2021 --
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of OMER is 4.41 USD — it has decreased by −2.00% in the past 24 hours. Watch Omeros Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Omeros Corporation stocks are traded under the ticker OMER.
OMER stock has risen by 8.09% compared to the previous week, the month change is a 15.14% rise, over the last year Omeros Corporation has showed a 224.26% increase.
OMER reached its all-time high on Aug 18, 2015 with the price of 30.23 USD, and its all-time low was 0.92 USD and was reached on Oct 16, 2023. View more price dynamics on OMER chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
OMER stock is 3.08% volatile and has beta coefficient of 1.86. Track Omeros Corporation stock price on the chart and check out the list of the most volatile stocks — is Omeros Corporation there?
Today Omeros Corporation has the market capitalization of 255.55 M, it has decreased by −0.47% over the last week.
Yes, you can track Omeros Corporation financials in yearly and quarterly reports right on TradingView.
Omeros Corporation is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
OMER earnings for the last quarter are −0.97 USD per share, whereas the estimation was −1.14 USD resulting in a 14.74% surprise. The estimated earnings for the next quarter are −0.70 USD per share. See more details about Omeros Corporation earnings.
Omeros Corporation revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
OMER net income for the last quarter is −56.04 M USD, while the quarter before that showed −37.18 M USD of net income which accounts for −50.71% change. Track more Omeros Corporation financial stats to get the full picture.
No, OMER doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 198.00 employees. See our rating of the largest employees — is Omeros Corporation on this list?
Like other stocks, OMER shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Omeros Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Omeros Corporation technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Omeros Corporation stock shows the buy signal. See more of Omeros Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.